I also spoke with Bruce Patterson after, about the (per misiu) Receptor Occupancy Test and if they going to use it in Pivotal Mono and he said "absolutely, in fact they (FDA) are requesting it, but its not a big deal because we have all the data. My machines are running tests all day long". He further said
"We now can prove with 100% certainty that a spike in VL is not drug related, but patient related and the FDA loves it".
He said he was just test bladder cancer and Leron and prelim results were off the chart.